WO1998037181A3 - Gene de sous-unite catalytique de telomerase et proteine codee - Google Patents
Gene de sous-unite catalytique de telomerase et proteine codee Download PDFInfo
- Publication number
- WO1998037181A3 WO1998037181A3 PCT/US1998/003404 US9803404W WO9837181A3 WO 1998037181 A3 WO1998037181 A3 WO 1998037181A3 US 9803404 W US9803404 W US 9803404W WO 9837181 A3 WO9837181 A3 WO 9837181A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- catalytic subunit
- malignancy
- telomerase
- encoded protein
- subunit gene
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1241—Nucleotidyltransferases (2.7.7)
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
Cette invention concerne de l'ADN isolé codant la sous-unité catalytique d'une holoenzyme de télomérase eucaryotique telle que la sous-unité catalytique d'une holoenzyme de télomérase humaine ou de levure; le transcript d'ARN qui est exprimé dans des tumeurs humaines primitives, des lignées cellulaires cancéreuses et des tissus télomérase-positifs; et la protéine de sous-unité catalytique codée. L'invention concerne également des procédés qui permettent d'évaluer le caractère malin des cellules ou la probabilité accrue que les cellules deviennent malignes et des méthodes de diagnostic ou facilitant le diagnostic du développement du caractère malin des cellules chez un individu.
Applications Claiming Priority (10)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US3875097P | 1997-02-20 | 1997-02-20 | |
US60/038,750 | 1997-02-20 | ||
US4715197P | 1997-05-20 | 1997-05-20 | |
US60/047,151 | 1997-05-20 | ||
US5454997P | 1997-08-01 | 1997-08-01 | |
US60/054,549 | 1997-08-01 | ||
US5576297P | 1997-08-14 | 1997-08-14 | |
US60/055,762 | 1997-08-14 | ||
US6432297P | 1997-10-30 | 1997-10-30 | |
US60/064,322 | 1997-10-30 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1998037181A2 WO1998037181A2 (fr) | 1998-08-27 |
WO1998037181A3 true WO1998037181A3 (fr) | 1999-02-18 |
Family
ID=27534674
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1998/003404 WO1998037181A2 (fr) | 1997-02-20 | 1998-02-20 | Gene de sous-unite catalytique de telomerase et proteine codee |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO1998037181A2 (fr) |
Families Citing this family (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19681033D2 (de) | 1995-11-16 | 1999-03-18 | Michael W Dahm | Verfahren zur Quantifizierung von Tumorzellen in einer Körperflüssigkeit und dazu geeignete Testkits |
US6777203B1 (en) | 1997-11-19 | 2004-08-17 | Geron Corporation | Telomerase promoter driving expression of therapeutic gene sequences |
US6610839B1 (en) | 1997-08-14 | 2003-08-26 | Geron Corporation | Promoter for telomerase reverse transcriptase |
WO1998014592A2 (fr) | 1996-10-01 | 1998-04-09 | Geron Corporation | Transcriptase inverse de la telomerase |
US6475789B1 (en) | 1996-10-01 | 2002-11-05 | University Technology Corporation | Human telomerase catalytic subunit: diagnostic and therapeutic methods |
US7585622B1 (en) | 1996-10-01 | 2009-09-08 | Geron Corporation | Increasing the proliferative capacity of cells using telomerase reverse transcriptase |
US6261836B1 (en) | 1996-10-01 | 2001-07-17 | Geron Corporation | Telomerase |
US6093809A (en) | 1996-10-01 | 2000-07-25 | University Technology Corporation | Telomerase |
US7622549B2 (en) | 1997-04-18 | 2009-11-24 | Geron Corporation | Human telomerase reverse transcriptase polypeptides |
US7413864B2 (en) | 1997-04-18 | 2008-08-19 | Geron Corporation | Treating cancer using a telomerase vaccine |
JP2002508662A (ja) * | 1997-06-20 | 2002-03-19 | バイエル・アクチエンゲゼルシヤフト | ヒトテロメラーゼの触媒サブユニット並びにその診断的及び治療的使用 |
CN1270634A (zh) | 1997-07-01 | 2000-10-18 | 卡姆比亚生物系统有限责任公司 | 脊椎动物端粒酶基因和蛋白质及其用途 |
EP1571215A3 (fr) * | 1997-07-01 | 2007-10-31 | Cambia Biosystems LLC | Gènes et protéines de télomérases de vertèbres et leurs utilisations |
US7378244B2 (en) | 1997-10-01 | 2008-05-27 | Geron Corporation | Telomerase promoters sequences for screening telomerase modulators |
WO1999027113A1 (fr) * | 1997-11-26 | 1999-06-03 | Geron Corporation | Transcriptase inverse de telomerase de souris |
WO1999035261A1 (fr) | 1998-01-08 | 1999-07-15 | Chugai Seiyaku Kabushiki Kaisha | Nouveau gene presentant un motif de transcriptase inverse |
DE19804372A1 (de) | 1998-02-04 | 1999-08-05 | Michael W Dr Dr Dahm | Verfahren zur quantitativen Bestimmung von Tumorzellen in einer Körperflüssigkeit und dazu geeignete Testkits |
EP0990701A4 (fr) * | 1998-03-26 | 2001-12-12 | Kyowa Hakko Kogyo Kk | Anticorps monoclonal contre une sous-unite catalytique de telomerase humaine |
JP2002509716A (ja) | 1998-03-31 | 2002-04-02 | ユニバーシティ テクノロジー コーポレイション | テロメラーゼ抗原に対する免疫応答を惹起するための方法および組成物 |
US6337200B1 (en) * | 1998-03-31 | 2002-01-08 | Geron Corporation | Human telomerase catalytic subunit variants |
US7402307B2 (en) | 1998-03-31 | 2008-07-22 | Geron Corporation | Method for identifying and killing cancer cells |
DE69934426T2 (de) | 1998-10-29 | 2007-10-04 | Whitehead Institute For Biomedical Research, Cambridge | KREBSIMMUNTHERAPIE UND KREBSDIAGNOSE UNTER VERWENDUNG UNIVERSELLER TUMORASSOZIIERTER ANTIGENE EINSCHLIESSLICH hTERT |
US6825397B1 (en) | 1998-11-09 | 2004-11-30 | Pioneer Hi-Bred International, Inc. | LEC1 trancriptional activator nucleic acids and methods of use thereof |
JP2002530436A (ja) * | 1998-11-25 | 2002-09-17 | ジェネティカ インコーポレイテッド | 増殖能を増強しかつ複製老化を防止する方法及び試薬 |
US6399384B1 (en) * | 1999-09-17 | 2002-06-04 | Reneuron Limited | Conditional immortalization of cells |
KR100801764B1 (ko) * | 1999-09-17 | 2008-02-05 | 레뉴런 리미티드 | 세포의 조건부 불멸화 |
US6492171B2 (en) | 2000-05-16 | 2002-12-10 | Isis Pharmaceuticals, Inc. | Antisense modulation of TERT expression |
US6331399B1 (en) | 2000-05-16 | 2001-12-18 | Isis Pharmaceuticals, Inc. | Antisense inhibition of tert expression |
AU2001282290A1 (en) * | 2000-08-17 | 2002-03-04 | University Of Wales College Of Medicine | Htert-immortalised cell lines, their preparation and use |
US7078491B1 (en) * | 2000-09-21 | 2006-07-18 | Amgen Inc. | Selective binding agents of telomerase |
GB0125773D0 (en) * | 2001-10-26 | 2001-12-19 | Reneuron Ltd | Constructs |
US20050089895A1 (en) * | 2003-08-13 | 2005-04-28 | Cheung Siu T. | Compositions and methods for prognosis and therapy of liver cancer |
ES2376010T3 (es) | 2006-10-12 | 2012-03-08 | Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.R.L. | Prote�?na de fusión de transcriptasa inversa de la telomerasa, nucleótidos que la codifican y usos de la misma. |
US10689652B2 (en) | 2013-10-02 | 2020-06-23 | The Regents Of The University Of California | Methods for immortalization of epithelial cells |
WO2017062517A1 (fr) * | 2015-10-06 | 2017-04-13 | The Regents Of The University Of California | Arn non codants liés à l'immortalité ainsi que compositions et procédés associés |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993023572A1 (fr) * | 1992-05-13 | 1993-11-25 | University Of Texas Southwestern Medical Center At Dallas | Therapie et diagnostic des etats pathologiques lies a la longueur du telomere et/ou a l'activite de la telomerase |
WO1996001835A1 (fr) * | 1994-07-07 | 1996-01-25 | Geron Corporation | Telomerase mammifere |
WO1996012811A2 (fr) * | 1994-10-20 | 1996-05-02 | Arch Development Corporation | Constituants de levure-telomerase et leurs procedes d'utilisation |
WO1998001542A1 (fr) * | 1996-07-08 | 1998-01-15 | The Regents Of The University Of California | Telomerase humaine |
GB2317891A (en) * | 1996-10-01 | 1998-04-08 | Geron Corp | hTRT, the reverse transcriptase subunit of human telomerase |
WO1998021343A1 (fr) * | 1996-11-15 | 1998-05-22 | Amgen Inc. | Genes codant des proteines de telomerase |
-
1998
- 1998-02-20 WO PCT/US1998/003404 patent/WO1998037181A2/fr active Application Filing
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993023572A1 (fr) * | 1992-05-13 | 1993-11-25 | University Of Texas Southwestern Medical Center At Dallas | Therapie et diagnostic des etats pathologiques lies a la longueur du telomere et/ou a l'activite de la telomerase |
WO1996001835A1 (fr) * | 1994-07-07 | 1996-01-25 | Geron Corporation | Telomerase mammifere |
WO1996012811A2 (fr) * | 1994-10-20 | 1996-05-02 | Arch Development Corporation | Constituants de levure-telomerase et leurs procedes d'utilisation |
WO1998001542A1 (fr) * | 1996-07-08 | 1998-01-15 | The Regents Of The University Of California | Telomerase humaine |
GB2317891A (en) * | 1996-10-01 | 1998-04-08 | Geron Corp | hTRT, the reverse transcriptase subunit of human telomerase |
WO1998021343A1 (fr) * | 1996-11-15 | 1998-05-22 | Amgen Inc. | Genes codant des proteines de telomerase |
Non-Patent Citations (7)
Title |
---|
COUNTER C M ET AL: "The catalytic subunit of yeast telomerase", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA., vol. 94, no. 17, 1997, WASHINGTON US, pages 9202 - 9207, XP002071610 * |
GREIDER C W: "TELOMERE LENGTH REGULATION", ANNUAL REVIEW OF BIOCHEMISTRY, vol. 65, 1996, PALO ALTO US, pages 337 - 365, XP002056801 * |
HARRINGTON L ET AL: "HUMAN TELOMERASE CONTAINS EVOLUTIONARILY CONSERVED CATALYTIC AND STRUCTURAL SUBUNITS", GENES AND DEVELOPMENT, vol. 11, no. 23, 1 December 1997 (1997-12-01), COLD SPRING HARBOUR US, pages 3109 - 3115, XP002061269 * |
LENDVAY T S ET AL: "Senescence mutants of Saccharomyces cerevisiae with a defect in telomere replication identify three additional EST genes", GENETICS, vol. 144, no. 4, 1996, BETHESDA US, pages 1399 - 1412, XP002071608 * |
LINGNER J ET AL: "Reverse transcriptase motifs in the catalytic subunit of telomerase", SCIENCE., vol. 276, no. 5312, 25 April 1997 (1997-04-25), LANCASTER, PA US, pages 561 - 567, XP002071609 * |
MEYERSON M ET AL: "HEST2, THE PUTATIVE HUMAN TELOMERASE CATALYTIC SUBUNIT GENE, IS UP-REGULATED IN TUMOR CELLS AND DURING IMMORTALIZATION", CELL, vol. 90, no. 4, 22 August 1997 (1997-08-22), NA US, pages 785 - 795, XP002056804 * |
NAKAMURA T M ET AL: "TELOMERASE CATALYTIC SUBUNIT HOMOLOGS FROM FISSION YEAST AND HUMAN", SCIENCE., vol. 277, 15 August 1997 (1997-08-15), LANCASTER, PA US, pages 955 - 959, XP002056803 * |
Also Published As
Publication number | Publication date |
---|---|
WO1998037181A2 (fr) | 1998-08-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1998037181A3 (fr) | Gene de sous-unite catalytique de telomerase et proteine codee | |
WO2000060058A3 (fr) | Polypeptides possedant une activite alcaline alpha-amylase et acides nucleiques codant pour ces polypeptides | |
WO2001051633A3 (fr) | Compositions et methodes destinees au traitement et au diagnostique du cancer de la prostate | |
WO2001073032A3 (fr) | Compositions et methodes de therapie et de diagnostic du cancer de la prostate | |
ES2255281T3 (es) | Sobreexpresion de genes de fitasa en sistmas de levadura. | |
WO2000027994A3 (fr) | Sequence genomique de chlamydia pneumoniae | |
WO2003022995A3 (fr) | Acide nucleique et proteine correspondante designes par steap-1 utiles dans le traitement et la detection du cancer | |
WO1999040189A3 (fr) | ADNc CODANT DES PROTEINES SECRETEES | |
WO2002089747A3 (fr) | Compositions et procedes pour la therapie et le diagnostic du cancer de la prostate | |
WO2003040340A3 (fr) | Acide nucleique et proteine correspondante 161p2f10b utiles dans le traitement et le depistage du cancer | |
WO2001034802A3 (fr) | Compositions et methodes de traitement et de diagnostic du cancer de la prostate | |
WO1999031236A3 (fr) | ADNc PROLONGES POUR PROTEINES SECRETEES | |
WO2001072295A3 (fr) | Compositions et methodes pouvant traiter ou diagnostiquer le cancer du poumon | |
WO2002012328A8 (fr) | Compositions et methodes utilisees dans la therapie et le diagnostic du cancer du colon | |
WO2000012702A3 (fr) | Genes humains exprimes de maniere differenciee dans un cancer colorectal | |
WO2002058534A3 (fr) | Compositions et methodes pour le traitement et le diagnostic du cancer du colon | |
WO2000042208A8 (fr) | Vecteurs d'adenovirus, lignees cellulaires d'encapsidation, compositions et procedes de preparation et d'utilisation correspondants | |
WO2001041815A3 (fr) | Genes de metastase et utilisations de tels genes | |
WO2003050255A3 (fr) | Acide nucleique et proteine correspondante appelee 193p1e1b utile dans le traitement et la detection du cancer | |
WO2003066663A3 (fr) | Peptides utilises pour reconnaitre et cibler des tumeurs de cellules gliales | |
WO2001077168A3 (fr) | Compositions et procedes permettant de traiter et de diagnostiquer le cancer du poumon | |
WO2002012280A3 (fr) | Compositions et procedes pour le diagnostic et le traitement du cancer du colon | |
WO1999054447A3 (fr) | Sequences d'acide nucleique provenant de tissus tumoraux de la vessie | |
WO2001038577A3 (fr) | Transcriptomes humains | |
CA2315239A1 (fr) | Sequence nucleotidique et proteinique de la mammastatine et procedes d'utilisation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): CA US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): CA US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
NENP | Non-entry into the national phase |
Ref country code: CA |
|
122 | Ep: pct application non-entry in european phase |